W. Nicholas Howley, a director at TransDigm Group INC (), sold shares totaling approximately $12.3 million on July 20, 2026. The transactions followed an exercise of stock options on the same day.
Mr. Howley disposed of a total of 10,132 shares of common stock through a series of transactions. The shares were sold at prices ranging from $1,210.3242 to $1,224.1377, amounting to a total value of $12,321,287. These shares were held indirectly through the W. Nicholas Howley Family Trust. The sale comes as TransDigm stock trades near $1,205, down roughly 18% over the past year. According to InvestingPro analysis, the stock appears slightly overvalued at current levels. The aerospace components manufacturer maintains a market capitalization of $67.4 billion and boasts impressive gross profit margins of nearly 60%. Investors can access detailed Fair Value analysis and comprehensive insights through the Pro Research Report available for TDG.
Prior to the sales, Mr. Howley acquired 10,132 shares of TransDigm common stock by exercising stock options. These shares were acquired at an exercise price of $66.47 per share, for a total value of $673,474. The exercise price reflects adjustments for dividends declared since August 1, 2022.
Following these reported transactions, the W. Nicholas Howley Family Trust indirectly holds 21,547.513 shares of TransDigm Group common stock.
In other recent news, TransDigm Group Incorporated reported impressive financial results for the second quarter of fiscal 2026, with earnings per share reaching $9.85, surpassing analyst expectations of $9.38. Revenue for the quarter was $2.54 billion, exceeding the anticipated $2.45 billion. These results indicate a positive surprise of 3.67% over projections. Additionally, TransDigm’s proposed $960 million acquisition of Stellant Systems was blocked by the Department of Justice due to concerns about creating a monopoly in certain product areas. Consequently, TransDigm decided to withdraw from the acquisition, and the seller terminated the transaction agreement. Following these developments, Morgan Stanley downgraded TransDigm’s stock rating from Overweight to Equalweight, citing valuation concerns and lowering the price target to $1,345. Meanwhile, TD Cowen reiterated a Buy rating with a $1,450 price target, despite the blocked acquisition. These recent developments highlight significant changes for TransDigm Group in the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
investment News
